Cellectar Begins New CLR 131 Trial
Cellectar Biosciences has started a trial for CLR 131 in Waldenstrom’s macroglobulinemia (WM), the company announced recently. According to a release, the trial will include 50 WM patients who will…
Category Archives: Biotech
NorthStar Receives FDA Approval for Production
NorthStar Medical Radioisotopes received approval from the U.S. Food and Drug Administration (FDA) to produce the isotope Molybdenum-99 (Mo-99) from concentrated Mo-98 (cMo-98), the company announced recently. “This approval of production…
Cellectar Prices Underwritten Public Offering
Cellectar Biosciences announced today the pricing of its underwritten public offering of its common stock at $1.35 per share, which will result in gross proceeds of approximately $24.5 million. Cellectar also…
SHINE Breaks Ground on HQ
SHINE Medical Technologies broke ground on its 54,000-square-foot corporate headquarters and therapeutics production facility in Janesville, Wis., the company announced recently. “The best work we do at SHINE is the…
SHINE to Add a Supercell to Facility
SHINE Medical Technologies will add a “supercell,” a bank of 10 hot cells, for its medical isotope production facility in Janesville, Wis., the company announced recently. According to a release,…
Imbed Biosciences Announces Study Results
Imbed Biosciences announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte Matrix, in complex chronic wounds. “This was a very professionally run prospective…
SHINE Makes First Sale of Lu-177 Isotope
SHINE Medical Technologies Therapeutics division has made its first commercial sale of lutetium-177, a therapeutic isotope in demand by clinical trial sponsors, the company announced recently. “This milestone is really exciting,…
Exact Sciences Acquires Two Firms
Exact Sciences announced today it will acquire Thrive Earlier Detection Corp. for $2.15 billion and Base Genomics for an undisclosed sum. Both companies specialize in cancer screening blood tests. According to…
Exact Sciences Adds New Cancer Test
Exact Sciences has introduced its Oncotype MAP Pan-Cancer Tissue test for patients with advanced, metastatic, refractory or recurrent cancer, the company announced today. According to a release, the Oncotype MAP…
Exact Sciences, Pfizer Extend Agreement
Exact Sciences has extended and made amendments to its agreement with Pfizer to promote Cologuard, the company announced recently. “We’re thrilled to continue working with Pfizer to increase screening rates with…
